REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 113 filers reported holding REVANCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,664 | -54.3% | 20,982 | +0.8% | 0.00% | -100.0% |
| Q2 2023 | $526,625 | -32.6% | 20,807 | -14.2% | 0.00% | -50.0% |
| Q1 2023 | $781,157 | -38.3% | 24,252 | -64.6% | 0.00% | -33.3% |
| Q4 2022 | $1,266,042 | -57.8% | 68,583 | -38.2% | 0.00% | -66.7% |
| Q3 2022 | $2,997,000 | +277.0% | 110,988 | +93.0% | 0.01% | +200.0% |
| Q2 2022 | $795,000 | -59.4% | 57,498 | -42.7% | 0.00% | -50.0% |
| Q1 2022 | $1,956,000 | +210.0% | 100,300 | +159.7% | 0.01% | +200.0% |
| Q4 2021 | $631,000 | +45.1% | 38,620 | +147.6% | 0.00% | +100.0% |
| Q3 2021 | $435,000 | -71.3% | 15,600 | -69.5% | 0.00% | -83.3% |
| Q2 2021 | $1,514,000 | -18.3% | 51,091 | -21.9% | 0.01% | -25.0% |
| Q4 2020 | $1,853,000 | +808.3% | 65,400 | +707.4% | 0.01% | +700.0% |
| Q3 2020 | $204,000 | -61.8% | 8,100 | -62.3% | 0.00% | -66.7% |
| Q3 2018 | $534,000 | +30.2% | 21,501 | +43.9% | 0.00% | +50.0% |
| Q2 2018 | $410,000 | – | 14,939 | +373375.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 4 | -98.7% | 0.00% | – |
| Q2 2015 | $10,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |